NUZ — Neurizon Therapeutics Share News
0.000.00%
Last trade - 00:00- AU$62.62m
- AU$53.22m
Australia Stock Exchange release from PHARMAUST : Preliminary MPL antiviral leukaemia preclinical WEHI results
Australia Stock Exchange release from PHARMAUST : PRE_NR Ends: 11:24:58
Australia Stock Exchange release from PHARMAUST : Key Appointment to Progress MPL COVID-19 Clinical Trial
Australia Stock Exchange release from PHARMAUST : PRE_NR Ends: 08:15:28
Australia Stock Exchange release from PHARMAUST : Appendix 4D & Half Year Report
Australia Stock Exchange release from PHARMAUST : PRE_NR Ends: 18:04:56
Australia Stock Exchange release from PHARMAUST : PRE_NR Ends: 08:21:59
Australia Stock Exchange release from PHARMAUST : Epichem Confirms Effectiveness of OHD E-Waste Project
Australia Stock Exchange release from PHARMAUST : Resignation of Epichem CEO
Australia Stock Exchange release from PHARMAUST : PRE_NR Ends: 09:36:21
Australia Stock Exchange release from PHARMAUST : Update on Manufacture of MPL & Tablets for Clinical Trials
Australia Stock Exchange release from PHARMAUST : PRE_NR Ends: 10:11:36
Australia Stock Exchange release from PHARMAUST : Appendix 4C and Quarterly Update
Brief: Pharmaust Says Unit Epichem Awarded Contract Extension
Australia Stock Exchange release from PHARMAUST : Epichem Awarded Contract Extension from DNDi
Australia Stock Exchange release from PHARMAUST : PRE_NR Ends: 09:22:35
Australia Stock Exchange release from PHARMAUST : Shareholder Update - Progress and Strategy
Australia Stock Exchange release from PHARMAUST : PRE_NR Ends: 09:00:21
Australia Stock Exchange release from PHARMAUST : Demonstration batch of smaller size MPL tablets completed